Ultimately, women defined as equol producers may experience direct beneficial effects from equol binding to DHT, preventing androgen receptor activation, or via a decrease in steroidogenic enzyme expression, as it has been shown in vitro and in a rat model of PCOS [32,106]. The gene discussed is AR; the disease is polycystic ovary syndrome.